Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands

Immunological Reviews

Volumn 177, Issue , 2000, Pages 112-126

  Simmons, Graham ^a,b,c,d   Reeves, Jacqueline D ^a,b,c,d   Hibbitts, Sam ^a,b,c,d   Stine, Johnny T ^a,b,c,d   Gray, Patrick W ^a,b,c,d   Proudfoot, Amanda E I ^a,b,c,d   Clapham, Paul R ^a,b,c,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; LIGAND; RANTES;

FIBROBLAST; HERPES VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION; VIRUS STRAIN;

EID: 0033659687     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2000.17719.x     Document Type: Review

References (150)

1. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
2. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV
3. CC CKR5: A RANTES, MIP-1α, MIP- 1β receptor as a fusion cofactor for macrophage-tropic HIV-1
4. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
5. Identification of a major coreceptor for primary isolates of HIV-1
6. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
7. + cells is mediated by the chemokine receptor CC-CKR-5
8. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
9. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry
10. A new classification for HIV-1
11. Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro
12. Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression
13. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
14. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
15. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study
16. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression
17. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: Studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk
18. Change in coreceptor use coreceptor use correlates with disease progression in HIV-1-infected individuals
19. Chemokine and orphan receptors in HIV-2 and SIV tropism and pathogenesis
20. HIV-2-infected patients survive longer than HIV-1-infected patients
21. + T cell decline
22. Biological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR
23. Patterns of chemokine receptor fusion cofactor utilization by human immunodeficiency virus type 1 variants from the lungs and blood
24. Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types
25. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture
26. Infection of monocyte/macrophages by human T lymphotropic virus type III
27. In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV)
28. Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent
29. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: Implications for HIV primary infection
30. Chemokine receptor regulation and HIV type 1 tropism in monocyte-macrophages
31. CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection
32. Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates
33. CXCR4 as a functional coreceptor for human immunodeficiency virus type 1 infection of primary macrophages
34. CXCR4 is a functional coreceptor for infection of human macrophages by CXCR4-dependent primary HIV-1 isolates
35. Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: Two distinct mechanisms of HIV-1 dual tropism
36. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy
37. AIDS subacute encephalitis. Identification of HIV-infected cells
38. Coreceptor ligand inhibition of fetal brain cell infection by HIV type 1
39. Biological and molecular characterization of human immunodeficiency virus (HIV-1BR) from the brain of a patient with progressive dementia
40. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms
41. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: Identification of replication-competent and -defective viral genomes
42. Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin
43. Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation
44. Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates
45. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
46. Role of the β-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia
47. CD4-independent infection by HIV-2 (ROD/B): Use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry
48. An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type 1 and simian immunodeficiency virus
49. An orphan G protein-coupled receptor, GPR1, acts as a coreceptor to allow replication of human immunodefidency virus types 1 and 2 in brain-derived cells
50. Identification of the chemokine receptor TER1/CCR8 expressed in brain-derived cells and T cells as a new coreceptor for HIV-1 infection
51. Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses
52. Patterns of CCR5, CXCR4, and CCR3 usage by envelope glycoproteins from human immunodeficiency virus type 1 primary isolates
53. Expression cloning of new receptors used by simian and human immunodeficiency viruses
54. ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains
55. Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: Resistance to patient-derived and prototype isolates resulting from the Δ CCR5 mutation
56. CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1
57. Usage of the coreceptors CCR-5, CCR-3, and CXCR-4 by primary and cell line-adapted human immunodeficiency virus type 2
58. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry
59. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: A comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac
60. Natural infection of a homozygous delta24 CCR5 red-capped mangabey with an R2b-tropic simian immunodeficiency virus
61. Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains
62. CXCR4 sequences involved in coreceptor determination of human immunodeficiency virus type-1 tropism. Unmasking of activity with M-tropic Env glycoproteins
63. Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates
64. Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion
65. HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor
66. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus
67. CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain
68. - negative cells via CCR5 and CXCR4: Comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo
69. Identification of determinants of interaction between CXCR4 and gp120 of a dual-tropic HIV-1DH12 isolate
70. Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4
71. + lymphocytes can control HIV infection in vitro by suppressing virus replication
72. + T lymphocytes suppresses HIV replication
73. + T cells
74. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
75. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
76. Association between CCR5 genotype and the clinical course of HIV-1 infection
77. Role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptacoccus neoformans
78. Defects in the generation of IFN-γ are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice
79. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor
80. A randomized phase-II study of BB-10010 (macrophage inflammatory protein-1α) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapy
81. Clinical effects of human macrophage inflammatory protein-1α MIP-1 α (LD78) admimstration to humans: A phase I study in cancer patients and normal healthy volunteers with the genetically engineered variant, BB-10010
82. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
83. + T-cell-derived soluble factor(s), but not β-chemokines RANTES, MIP-1 α, and MIP-1 β, suppress HIV-1 replication in monocyte/macrophages
84. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist
85. Regulation of anti-HIV-1 activity of RANTES by heparan sulfate proteoglycans
86. Dichotomous effects of β-chemokines on HIV replication in monocytes and monocyte-derived macrophages
87. Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1α, MIP-1β and RANTES β-chemokines
88. Interleukin-8 antagonists generated by N-terminal modification
89. Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues
90. HIV blocked by chemokine antagonist
91. Two-site binding of C5a by its receptor: An alternative binding paradigm for G protein-coupled receptors
92. The molecular basis of the chemokine/chemokine receptor interaction-scope for design of chemokine antagonists
93. Selectivity and antagonism of chemokine receptors
94. Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist
95. Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus
96. Similarities and differences in RANTES- and (AOP)-RANTES-triggered signals: Implications for chemotaxis
97. Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors
98. Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants
99. HIV coreceptor downregulation as antiviral principle: SDF-1α- dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication
100. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: Independence from G protein signaling and importance of coreceptor downmodulation
101. Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4
102. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: A novel inhibitory mechanism of HIV infectivity
103. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist
104. Phenotypic knockout of HIV type 1 chemokine coreceptor CCR-5 by intrakines as potential therapeutic approach for HIV-1 infection
105. Genetic co-inactivation of macrophage- and T-tropic HIV- 1 chemokine coreceptors CCR-5 and CXCR-4 by intrakines
106. Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion
107. Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop
108. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: Frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex
109. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression
110. HIV-1 entry inhibitors and virus emergence
111. HIV-1 infection in an individual homozygous for CCR5 Δ 32
112. HIV-1 infection in an individual homozygous for the CCR5 deletion allele
113. Homozygous Δ 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient
114. Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 Δ32
115. Kaposi's sarcoma-associated herpesvirus: The 2nd human gammaherpesvirus
116. HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines
117. In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II
118. One step ahead of the game: Viral immunomodulatory molecules
119. + cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance
120. The Kaposi's sarcoma-related herpesvirus (KSHV)-encoded chemokine vMIP- I is a specific agonist for the CC chemokine receptor (CCR)8
121. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines
122. KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells
123. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells
124. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
125. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
126. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells
127. The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant
128. Cloning of human genes encoding novel G protein-coupled receptors
129. A novel human gene encoding a G-protein-coupled receptor (GPR 15) is located on chromosome 3
130. Kaposi's sarcoma and protection from HIV dementia
131. Kaposi's sarcoma and protection from HIV dementia
132. Kaposi's sarcoma and protection from AIDS dementia complex
133. Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8 encephalitis in HIV-positive and -negative individuals
134. HHV-8/KSHV is not associated with AIDS-related primary central nervous system lymphoma
135. Detection of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus DNA in CSF from persons infected with HIV who had neurological disease
136. Chemokine inhibition of HIV infection
137. Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor
138. Coreceptor usage of human immunodeficiency virus type 2 primary isolates and biological clones is broad and does not correlate with their syncytium-inducing capacities
139. A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4
140. Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry
141. The orphan seven-transmembrane receptor apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1
142. Promiscuous use of CC and CXC chemokine receptors in cell-to-cell fusion mediated by a human immunodeficiency virus type 2 envelope protein
143. The simian immunodeficiency virus mnd(GB-1) strain uses CXCR4, not CCR5, as coreceptor for entry in human cells
144. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses
145. A CXC chemokine receptor, CXCR5/BLR1, is a novel and specific coreceptor for human immnnodeficiency virus type 2
146. Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immnnodeficiency virus infection
147. STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1
148. A putative G protein-coupled receptor, RDC1, is a novel coreceptor for human and simian immunodeficiency viruses
149. The leukotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells
150. Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry